NxGen™ RNAse Inhibitor, Biosearch Technologies

Supplier: LUCIGEN CORPORATION CA
NxGen™
30281-2 30281-1 30281-1 30281-2
CA97065-226EA 8514.16 CAD
CA97065-226 97065-226 CA97065-224 97065-224
NxGen™ RNAse Inhibitor, Biosearch Technologies
Proteins and Peptides
Eliminate RNAse activity with Lucigen’s NxGen™ RNAse Inhibitor.

RNAse Inhibitor is a potent inhibitor of ribonucleases such as RNase A, RNase B, and RNase C. The 52 kDa protein is a fusion of the porcine RNAse Inhibitor gene with a proprietary 22.5 kDa protein tag.

Performance Specifications: 1) Unit Concentration: 40,000 U/mL. 2) Purity (SDS-PAGE): >99%. 3) SS Exonuclease: 2000 U <5.0% released. 4) DS Exonuclease: 2000 U <0.5% released. 5) Endonuclease: 2000 U <10% converted. 6) Non-specific RNAse: 2000 U none detected. 7) E. coli 16S rDNA Contamination: 2000 U <10 copies. 8) Storage: -20°C.

Source: A recombinant E. coli strain carrying the porcine RNAse Inhibitor gene.

Ordering information: Supplied at 40,000 U/mL in 20 mM HEPES-KOH, 50 mM KCl, 8 mM dithiothreitol, 50% glycerol, pH 7.5 @ 25°C. Unit definition: One unit is defined as the amount of enzyme required to inhibit by 50% the hydrolysis of cytidine 2',3'-cyclic monophosphate by 5 ng of RNAse A.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR